HOME • BLOGS
Our Blogs: Where Science Meets Soul
This isn’t just another blog roll—it’s a living archive of bold ideas, biotech breakthroughs, and the human stories behind the science.
Five High Impact Moves to Maximize Biotech R&D with Limited Resources
- Ndeye Makalou, Pharm D. MSc.
- }Reading Time: 4-5 minutes
Situation
With capital scarce, speed and focus decide who wins. Many teams are spread thin across too many assets and vendors.
Analysis
Five moves consistently unlock momentum:
- Ruthless Pipeline Triage: double down on assets with clear line‑of‑sight to de‑risking milestones.
- Partner Smart + Non‑Dilutive Funding: treat NIH/BARDA/EU calls as a quarterly sprint.
- Tune the CRO Stack: milestone‑based contracts; exit underperformers quickly.
- Shrink Decision Latency: owner‑led micro‑teams; weekly “what’s critical” standups.
- Protect Talent: role clarity, visible wins, flexible work that retains A‑players.
Recommendation
Adopt a 90‑day operating system: a single priority per asset, milestone‑based budgets, and a vendor scorecard. Review monthly and adjust quarterly.
Expected Impact
Fewer delays, higher probability of technical and regulatory success, and a clearer story for investors.
Dive Into More Stories
Situation: GenAI can accelerate writing, analysis, and knowledge discovery across R&D and operations—but only if it’s tied to specific business ou...
Situation: Biopharma moves in waves: science, regulation, and capital cycles. The leaders who consistently outperform aren’t luckier; they’ve buil...
Are You Ready For Your Next Stage of Growth?
Schedule your strategy session today and discover how GIBC can help you:
Enter new
global markets
global markets
Strengthen
operations
operations
Lead with purpose
and innovation
and innovation
Enter new
global markets
global markets
Strengthen
operations
operations
Lead with purpose
and innovation
and innovation